TipRanks
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
Australian Market
OSL
OncoSil Medical Ltd
RESEARCH TOOLSreports
Want to see AU:OSL full AI Analyst Report?

OncoSil Medical Ltd (OSL) Ratios

19 Followers

OncoSil Medical Ltd Ratios

AU:OSL's free cash flow for Q4 2026 was AU$-3.29. For the 2026 fiscal year, AU:OSL's free cash flow was decreased by AU$ and operating cash flow was AU$-8.26. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 1.77 1.77 1.67 3.26 7.16
Quick Ratio
 1.77 1.77 1.67 3.19 7.16
Cash Ratio
 1.22 1.22 1.27 2.32 5.99
Solvency Ratio
 -2.03 -2.03 -3.72 -5.99 -7.01
Operating Cash Flow Ratio
 -1.97 -1.97 -2.99 -5.57 -7.21
Short-Term Operating Cash Flow Coverage
 -708.46 -708.46 0.00 -335.97 -77.37
Net Current Asset Value
AU$ 4.07MAU$ 4.07MAU$ 2.68MAU$ 4.35MAU$ 9.64M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.02 0.01 0.02
Debt-to-Capital Ratio
 <0.01 <0.01 0.02 0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.06 2.06 2.30 1.42 1.16
Debt Service Coverage Ratio
 -331.03 -346.84 -20.36K -328.13 -64.06
Interest Coverage Ratio
 -787.49 -858.22 -21.45K -3.31K -1.15K
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.45 0.45 0.33 0.34 0.83
Profitability Margins
Gross Profit Margin
-367.72%-367.72%-92.49%-192.21%-332.08%
EBIT Margin
-855.64%-855.64%-1289.65%-2319.64%-3082.87%
EBITDA Margin
-852.10%-852.10%-1286.60%-2499.74%-3037.18%
Operating Profit Margin
-855.64%-855.64%-1322.94%-2522.68%-3414.28%
Pretax Profit Margin
-846.55%-846.55%-1289.71%-2509.02%-3384.22%
Net Profit Margin
-644.53%-644.53%-1289.71%-2306.09%-3085.04%
Continuous Operations Profit Margin
-644.53%-644.53%-1289.71%-2306.09%-3085.04%
Net Income Per EBT
76.14%76.14%100.00%91.91%91.16%
EBT Per EBIT
98.94%98.94%97.49%99.46%99.12%
Return on Assets (ROA)
-105.32%-105.32%-211.24%-177.33%-98.86%
Return on Equity (ROE)
-245.90%-217.36%-486.54%-251.54%-114.80%
Return on Capital Employed (ROCE)
-288.11%-288.11%-496.48%-272.95%-126.74%
Return on Invested Capital (ROIC)
-218.71%-218.71%-476.30%-247.53%-112.22%
Return on Tangible Assets
-105.32%-105.32%-211.24%-177.33%-98.86%
Earnings Yield
-50.53%-67.53%-115.14%-0.27%-0.21%
Efficiency Ratios
Receivables Turnover
 0.69 0.69 0.97 0.42 0.29
Payables Turnover
 2.45 2.45 1.18 1.34 1.65
Inventory Turnover
 1.41K 1.41K 0.00 12.40 0.00
Fixed Asset Turnover
 1.81 1.81 2.76 1.33 1.54
Asset Turnover
 0.16 0.16 0.16 0.08 0.03
Working Capital Turnover Ratio
 0.45 0.50 0.33 0.07 0.04
Cash Conversion Cycle
 380.72 380.72 65.29 633.84 1.06K
Days of Sales Outstanding
 529.36 529.36 375.52 875.96 1.28K
Days of Inventory Outstanding
 0.26 0.26 0.00 29.44 0.00
Days of Payables Outstanding
 148.90 148.90 310.22 271.56 220.59
Operating Cycle
 529.62 529.62 375.52 905.40 1.28K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.39 -0.46 -1.10 >-0.01 >-0.01
Free Cash Flow Per Share
 -0.39 -0.46 -1.11 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
 -7.21K -7.21K -806.09 -54.93 -195.71
Capital Expenditure Coverage Ratio
 -7.21K -7.21K -806.09 -54.93 -195.71
Operating Cash Flow Coverage Ratio
 -708.46 -708.46 -172.53 -153.16 -66.25
Operating Cash Flow to Sales Ratio
 -6.22 -6.22 -10.30 -20.95 -30.78
Free Cash Flow Yield
-42.38%-65.13%-92.09%-0.25%-0.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.53 -1.48 -0.87 -372.57 -477.66
Price-to-Sales (P/S) Ratio
 13.47 9.54 11.20 8.59K 14.74K
Price-to-Book (P/B) Ratio
 3.95 3.22 4.23 937.16 548.36
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.17 -1.54 -1.09 -402.74 -476.38
Price-to-Operating Cash Flow Ratio
 -1.89 -1.54 -1.09 -410.07 -478.81
Price-to-Earnings Growth (PEG) Ratio
 -0.04 0.02 >-0.01 8.76 68.92
Enterprise Value Multiple
 -1.13 -0.67 -0.54 -343.36 -484.36
Enterprise Value
 18.25M 9.62M 8.07M 4.43B 5.41B
EV to EBITDA
 -1.27 -0.67 -0.54 -343.36 -484.36
EV to Sales
 10.83 5.71 6.90 8.58K 14.71K
EV to Free Cash Flow
 -1.74 -0.92 -0.67 -402.34 -475.57
EV to Operating Cash Flow
 -1.74 -0.92 -0.67 -409.67 -478.00
Tangible Book Value Per Share
 0.19 0.22 0.28 <0.01 <0.01
Shareholders’ Equity Per Share
 0.19 0.22 0.28 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.02 0.08 0.09
Revenue Per Share
 0.06 0.07 0.11 <0.01 <0.01
Net Income Per Share
 -0.40 -0.48 -1.38 >-0.01 >-0.01
Tax Burden
 0.76 0.76 1.00 0.92 0.91
Interest Burden
 0.99 0.99 1.00 1.08 1.10
Research & Development to Revenue
 3.25 3.25 3.60 5.79 7.75
SG&A to Revenue
 1.63 1.63 6.69 12.45 17.84
Stock-Based Compensation to Revenue
 0.00 0.00 0.57 1.19 1.05
Income Quality
 0.96 0.96 0.80 0.91 1.00
Currency in AUD